New Drugs

Brand/Generic Company Description
Ayvakit
avapritinib
Click here for more information
Blueprint Medicines

A kinase inhibitor for advanced gastrointestinal stromal tumor (GIST).

Palforzia
peanut (Arachis hypogaea) allergen powder-dnfp
Aimmune Therapeutics

An oral immunotherapy for patients with peanut allergy.

Tazverik
tazemetostat
Click here for more information
Epizyme

A methyltransferase inhibitor for advanced epithelioid sarcoma.

Tepezza
teprotumumab-trbw
Click here for more information
Horizon

A monoclonal antibody for thyroid eye disease.

Brand/Generic Company Description
Bynfezia Pen
octreotide
Click here for more information
Sun Pharm.

New subcutaneous pen formulation for patients with acromegaly, carcinoid tumors, or vasoactive intestinal peptide tumors.

Monoferric
ferric derisomaltose
Click here for more information
Pharmacosmos

An intravenous iron replacement formulation for iron deficiency anemia.

Trijardy XR
empagliflozin/linagliptin/metformin
Click here for more information
Boehringer Ingelheim

New combination formulation for glycemic control in patients with type 2 diabetes.

Valtoco
diazepam nasal spray
Click here for more information
Neurelis

New nasal spray formulation for acute treatment of seizure clusters and acute repetitive seizures.

Brand/Generic Company Description
Belviq, Belviq XR
lorcaserin
Click here for more information
Eisai

Voluntary withdrawal from the market due to concerns about an increased occurrence of cancer seen in a clinical trial.